Benzamide riboside induced mitochondrial mediated apoptosis in human lung cancer H520 cells

Life Sciences

Volumn 75, Issue 2, 2004, Pages 179-190

  Khanna, Neeru ^a   Jayaram, H N ^b   Singh, Neeta ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Benzamide riboside; Caspases; Cytochrome C; H520 cells; Mitochondria

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOSIS INDUCING FACTOR; BENZAMIDE RIBOSIDE; CASPASE 3; CYTOCHROME C; INOSINATE DEHYDROGENASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL DEATH; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MITOCHONDRION; NICK END LABELING; PROTEIN TARGETING; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CASPASE 3; CASPASES; FLOW CYTOMETRY; HUMANS; IMP DEHYDROGENASE; IN SITU NICK-END LABELING; LUNG NEOPLASMS; MITOCHONDRIA; NUCLEOSIDES; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 2142754435     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.11.026     Document Type: Article

References (30)

1. Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol. 39(11):2003;615-647
2. Calviello G., Di Nicuolo F., Piccioni E., Marcocci M.E., Serini S., Maggiano N., Jones K.H., Cornwell D.G., Palozza P. Gamma-Tocopheryl quinone induces apoptosis in cancer cells via caspase-9 activation and cytochrome c release. Carcinogenesis. 24(3):2003;427-433
3. Comis R.L., Friedland D.M., Good B.C. Small-cell lung cancer: a perspective on the past and a preview of the future. Oncology (Huntingt). 12(1 Suppl. 2):1998;44-50
4. Dempsey P.W., Doyle S.E., He J.Q., Cheng G. The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev. 14(3-4):2003;193-209
5. Gharehbaghi K., Grunberger W., Jayaram H.N. Studies on the mechanism of action of benzamide riboside: a novel inhibitor of IMP dehydrogenase. Curr Med Chem. 9(7):2002;743-748
6. Gorman A.M., Bonfoco E., Zhivotovsky B., Orrenius S., Ceccatelli S. Cytochrome c release and caspase-3 activation during colchicine-induced apoptosis of cerebellar granule cells. Eur J Neurosci. 11(3):1999;1067-1072
7. Grusch M., Rosenberger G., Fuhrmann G., Braun K., Titscher B., Szekeres T., Fritzer-Skekeres M., Oberhuber G., Krohn K., Hengstschlaeger M., Krupitza G., Jayaram H.N. Benzamide riboside induces apoptosis independent of Cdc25A expression in human ovarian carcinoma N.1 cells. Cell Death Differ. 6(8):1999;736-744
8. Hunakova L., Bies J., Sedlak J., Duraj J., Jakubikova J., Takacsova X., Novotny L., Chorvath B. Differential sensitivity of ovarian carcinoma cell lines to apoptosis induced by the IMPDH inhibitor benzamide riboside. Neoplasma. 47(5):2000;274-279
9. Jayaram H.N., Cooney D.A., Grusch M. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis. Curr Med Chem. 6(7):1999;561-574
10. Jayaram H.N., Gharehbaghi K., Jayaram N.H., Rieser J., Krohn K., Paull K.D. Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cells. Biochem Biophys Res Commun. 186(3):1992;1600-1606
11. Ji C., Amarnath V., Pietenpol J.A., Marnett L.J. 4-hydroxynonenal induces apoptosis via caspase-3 activation and cytochrome c release. Chem Res Toxicol. 14(8):2001;1090-1096
12. Joseph B., Lewensohn R., Zhivotovsky B. Role of apoptosis in the response of lung carcinomas to anti-cancer treatment. Ann N Y Acad Sci. 926:2000;204-216
13. Khanna N., Sen S., Sharma H., Singh N. S29 ribosomal protein induces apoptosis in H520 cells and sensitizes them to chemotherapy. Biochem Biophys Res Commun. 304(1):2003;26-35
14. Mignotte B., Vayssiere J.L. Mitochondria and apoptosis. Eur J Biochem. 252(1):1998;1-15
15. Novotny L., Rauko P., Yalowitz J.A., Szekeres T. Antitumor activity of benzamide riboside in vitro and in vivo. Curr Med Chem. 9(7):2002;773-779
16. Owens A.H. Jr., Abeloff M.D. Neoplasms of the lung. Calabresi P., Schein P.S., Rosenberg S.A. Medical Oncology. 1985;715-757 Macmillan, New York
17. Pathak A.K., Singh N., Khanna N., Reddy V.G., Prasad K.N., Kochupillai V. Potentiation of the effect of paclitaxel and carboplatin by antioxidant mixture on human lung cancer H520 Cells. J Am Coll Nutr. 21(5):2002;416-421
18. Polgar D., Gfatter S., Uhl M., Kassie F., Leisser C., Krupitza G., Grusch M. Potential mechanisms of benzamide riboside mediated cell death. Curr Med Chem. 9(7):2002;765-771
19. Raucko P., Novotny L., Dovinova I., Hunakova L., Szekeres T., Jayaram H.N. Antitumor activity of Benzamide riboside and its combination with cisplatin and staurosporine. Eur J Pharm Sci. 12(4):2001;387-394
20. Reddy V.G., Khanna N., Singh N. Vitamin C augments chemotherapeutic response of cervical carcinoma HeLa cells by stabilizing P53. Biochem Biophys Res Commun. 282(2):2001;409-415
21. Regula K.M., Ens K., Kirshenbaum L.A. Mitochondria-assisted cell suicide: a license to kill. J Mol Cell Cardiol. 35(6):2003;559-567
22. Schottenfeld D. Epidemiology of lung cancer. Pass H.L., Mitchel J.B., Johnson D., Turrisi A.T. Lung cancer- principles and practice. 1996;305-322 Lippincott-Raven, New York/Philadelphia
23. Singh N., Khanna N., Sharma H., Kundu S., Azmi S. Insights into the molecular mechanism of apoptosis induced by TNF-alpha in mouse epidermal JB6-derived RT-101 cells. Biochem Biophys Res Commun. 295(1):2002;24-30
24. Singh N., Sun Y., Nakamura K., Smith M.R., Colburn N.H. C-JUN/AP-1 as possible mediators of tumor necrosis factor-alpha-induced apoptotic response in mouse JB6 tumor cells. Oncol Res. 7(7-8):1995;353-362
25. Solary E., Bettaieb A., Dubrez-Daloz L., Corcos L. Mitochondria as a target for inducing death of malignant hematopoietic cells. Leuk Lymphoma. 44(4):2003;563-574
26. Travis W.D., Linder J., Mackay B. Classification, histology, cytology and electron microscopy. Pass H.I., Mitchel J.B., Johnson D., Turrisi A.T. Lung cancer- principles and practice. 1996;361-395 Lippincott-Raven Publ.
27. Voehringer D.W., Meyn R.E. Redox aspects of Bcl-2 function. Antioxid Redox Signal. 2(3):2000;537-550
28. Wei M.C., Zong W.X., Cheng E.H., Lindsten T., Panoutsakopoulou V., Ross A.J., Roth K.A., MacGregor G.R., Thompson C.B., Korsmeyer S.J. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 292(5517):2001;727-730
29. Yalowitz J.A., Jayaram H.N. Modulation of cytotoxicity of benzamide riboside by expression of NMN adenylyltransferase. Curr Med Chem. 9(7):2002;749-758
30. Yuan X.J., Whang Y.E. PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway. Oncogene. 21(2):2002;319-327